Enjoy complimentary customisation on priority with our Enterprise License!
The heart-lung machines market size is forecast to increase by USD 195.04 million at a CAGR of 3.89% between 2022 and 2027. The market is experiencing significant growth due to several key drivers. One of the primary factors is the increasing trend of medical tourism in Asia, which is leading to a higher demand for advanced medical equipment, including heart-lung machines. Another trend is the development of portable heart-lung machines, which offer greater mobility and flexibility for medical professionals. However, the market also faces challenges, such as the complications associated with coronary artery bypass grafting (CABG) surgeries, which can increase the need for heart-lung machines. These complications include bleeding, infection, and stroke, among others. Despite these challenges, the market is expected to continue growing due to the increasing demand for advanced medical equipment and the ongoing development of new technologies.
The global market is expected to experience significant growth due to the increasing prevalence of cardiovascular disorders, particularly in the geriatric population. These machines play a crucial role in supporting the heart and lungs during surgeries such as open-heart surgery, transplant surgeries, and heart valve surgeries. The clinical benefits of heart-lung machines are immense, enabling skilled medical professionals to perform complex procedures with precision. Advanced technology and engineering have led to the development of specialized cardiac centers equipped with sophisticated medical devices, including cardiopulmonary bypass machines and heart-lung machines. FDA clearance for these devices ensures their safety and efficacy in treating various cardiovascular diseases, lung diseases, and respiratory failure.
Heart-lung machines are essential in healthcare facilities for treating stress-induced cardiac and respiratory conditions, as well as those resulting from unhealthy food habits. The healthcare system relies heavily on these machines for organ transplants, offering new life to patients suffering from heart implants and other cardiovascular ailments. The market for heart-lung machines is expected to continue growing, driven by the increasing demand for advanced medical devices in the healthcare industry.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2023-2027, as well as historical data from 2017 - 2021 for the following segments.
The hospitals segment is estimated to witness significant growth during the forecast period. The market is witnessing significant growth due to the increasing number of transplant surgeries in the geriatric population. These medical devices, which include pumps, oxygenators, and monitoring systems, play a crucial role in maintaining organ function during surgeries for conditions such as coronary artery disease, heart failure, valvular heart disease, and congenital heart diseases. Specialized cardiac centers are investing in advanced technology to improve clinical benefits and ensure patient safety during elective surgeries. Engineering innovations in heart-lung machines have led to the development of specialized features like single roller pumps, safety mechanisms, bubble detectors, air removal systems, pressure alarms, and occlusion sensors.
These technologies help prevent complications such as hemolysis, organ ischemia, and tissue damage during surgical procedures. Surgical volume is increasing due to infection control protocols and minimally invasive procedures like CABG surgeries, robotic-assisted surgeries, and transcatheter interventions. Hospitals and clinics are focusing on therapeutic outcomes to enhance patient visits and overall satisfaction. According to WHO data, the number of cardiac surgeries is projected to grow, driving the demand for heart-lung machines in the healthcare industry.
Get a glance at the market share of various segments Request Free Sample
The Hospitals segment was valued at USD 622.13 million in 2017 and showed a gradual increase during the forecast period.
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
Heart-lung machines, also known as cardiopulmonary bypass machines, play a crucial role in organ transplant surgeries and open-heart procedures. These advanced medical devices enable skilled medical professionals to perform complex surgeries, including heart valve replacements and implants, by taking over the functions of the heart and lungs during the procedure. With an increasing number of cardiovascular diseases and lung disorders, the demand for heart-lung machines in hospitals and healthcare facilities is on the rise. FDA clearance is mandatory for the use of these machines in healthcare systems. Open-heart surgeries, heart transplants, and lung transplants have become common treatments for organ failure caused by stress, unhealthy food habits, obesity, disrupted sleep cycles, and various diseases such as cardiac stroke.
Advanced techniques and healthcare centers offer respiratory failure treatment using heart-lung machines, ensuring the safety and well-being of patients. Cardiopulmonary bypass machines are essential tools for healthcare professionals during surgeries, enabling them to maintain optimal patient conditions while addressing complex medical issues. The use of these machines has significantly improved the success rates of implant procedures and disease diagnosis, reducing deaths and enhancing patient outcomes. Surgical centers and healthcare systems continue to invest in heart-lung machines to provide high-quality care to patients dealing with various heart and lung conditions.
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increased medical tourism in Asia is the key driver of the market. The geriatric population is witnessing a significant increase in the prevalence of cardiovascular diseases (CVDs), leading to an escalating demand for heart-lung machines in transplant surgeries. Advanced technology and engineering in medical devices, including pumps, oxygenators, and monitoring systems, offer clinical benefits during complex cardiac procedures. Specialized cardiac centers in Asia, with their sophisticated infrastructure and infection control protocols, attract patients from around the world for elective surgeries. The surgical volume for cardiac procedures, such as coronary artery disease treatment, heart failure management, valvular heart disease interventions, CABG surgeries, minimally invasive procedures, robotic-assisted surgeries, and transcatheter interventions, is on the rise.
This trend is driven by the availability of skilled medical professionals, improved patient outcomes, and the affordability of healthcare services. WHO data indicates that organ ischemia and tissue damage during surgeries can lead to organ function decline. Therefore, safety mechanisms, such as bubble detectors, air removal systems, pressure alarms, and occlusion sensors, are essential to prevent complications like hemolysis. Hospitals and clinics in Asia offer diagnostic and treatment services for congenital heart diseases using single roller pumps and other advanced technologies. Patient visits for regular check-ups and maintenance, as well as calibration of heart-lung machines, are crucial to ensure optimal performance and therapeutic outcomes.
The market for heart-lung machines is expected to grow, as more surgical procedures are performed to save lives and improve patient quality of life.
Portable heart-lung machines is the upcoming trend in the market. Portable heart-lung machines, a modern medical innovation, offer significant clinical benefits for geriatric populations and those undergoing transplant surgeries. These advanced medical devices, which incorporate specialized engineering in the form of pumps, oxygenators, and monitoring systems, enable extracorporeal circulation during emergencies or elective surgeries. The compact size and rechargeable battery of these machines allow them to be transported throughout hospitals, providing accessibility for patients in various clinical settings. Vendors, such as MAQUET, a subsidiary of Getinge Group, have developed portable heart-lung machines like the CARDIOHELP System. This innovative device, renowned for its small size, has gained popularity in specialized cardiac centers in Europe, including Germany and the UK.
The clinical advantages of these machines extend to various surgical procedures, including coronary artery disease interventions, heart failure treatments, valvular heart disease surgeries, CABG procedures, minimally invasive surgeries, robotic-assisted surgeries, transcatheter interventions, and congenital heart disease treatments. Portable heart-lung machines ensure organ function preservation during surgeries, minimizing organ ischemia and tissue damage. These machines are essential for maintaining patient safety during complex procedures, with safety mechanisms such as bubble detectors, air removal systems, pressure alarms, and occlusion sensors. Despite their high cost, the long-term therapeutic outcomes and reduced need for patient visits for maintenance and calibration justify the investment.
According to WHO data, the global surgical volume for cardiac procedures is projected to increase, further emphasizing the importance of portable heart-lung machines in the healthcare sector.
Complications associated with CABG surgeries is a key challenge affecting the market growth. The market plays a crucial role in supporting patients undergoing complex cardiac surgeries, particularly during transplant procedures and those requiring prolonged cardiac arrest. In specialized cardiac centers, medical devices employing advanced technology, such as pumps, oxygenators, and monitoring systems, are utilized to maintain organ function during surgical interventions. These medical devices enable clinical benefits for various cardiac conditions, including coronary artery disease, heart failure, valvular heart disease, and congenital heart diseases. However, the use of heart-lung machines in surgeries, particularly in the geriatric population, comes with potential risks. The rigid tubes used for blood transportation can lead to complications such as infection, arrhythmia, kidney stress, and inflammation due to the release of cytokines.
The process of transferring blood through the machine can also cause hemolysis, rupturing cells and forming blood clots that may enter the body via the oxygenator, potentially leading to organ ischemia and tissue damage. To mitigate these risks, hospitals and clinics implement stringent infection control protocols, regular maintenance, and calibration of heart-lung machines. Elective surgeries are scheduled to ensure adequate patient visits for monitoring and follow-up care. Advanced safety mechanisms, such as bubble detectors, air removal systems, pressure alarms, and occlusion sensors, are integrated into the machines to minimize complications. Minimally invasive procedures, including robotic-assisted surgeries and transcatheter interventions, are increasingly being adopted to reduce the need for heart-lung machines and associated complications.
Despite these advancements, the surgical volume for cardiac procedures remains significant, driven by the increasing prevalence of cardiac conditions, such as heart failure and valvular heart disease. According to WHO data, an estimated 23 million people worldwide suffer from heart failure, and the number is projected to increase by 46% by 2030. The therapeutic outcomes of cardiac surgeries, including diagnosis and treatment, continue to be a focus for research and innovation in the field of medical engineering.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Axiomtek - The company offers heart lung machine solutions such as CEM313 and PICO512.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The heart-lung machine market is witnessing significant growth due to the increasing number of transplant surgeries and elective surgeries, particularly in specialized cardiac centers. The geriatric population, with a higher prevalence of coronary artery disease, heart failure, valvular heart disease, and congenital heart diseases, is driving the demand for advanced medical devices. These devices include pumps, oxygenators, and monitoring systems used in heart-lung machines. Advanced technology, engineering, and clinical benefits are key factors contributing to the growth of the market. The use of single roller pumps, safety mechanisms such as bubble detectors and air removal systems, and pressure alarms and occlusion sensors are essential features of heart-lung machines.
Maintenance, calibration, and infection control protocols are critical aspects of using heart-lung machines. The surgical volume for cardiac surgeries, including CABG surgeries, minimally invasive procedures, robotic-assisted surgeries, and transcatheter interventions, is increasing, leading to a higher demand for these medical devices. The diagnosis and treatment of organ ischemia and tissue damage during surgeries are crucial for positive therapeutic outcomes. According to the World Health Organization (WHO), cardiovascular diseases account for approximately 17.9 million deaths annually. This data highlights the importance of heart-lung machines in maintaining organ function during surgeries and ensuring patient safety. Hospitals and clinics are investing in these devices to improve patient care and surgical outcomes.
Market Scope |
|
Report Coverage |
Details |
Page number |
161 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.89% |
Market growth 2023-2027 |
USD 195.04 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
3.08 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 36% |
Key countries |
US, Germany, France, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Axiomtek, Braile Biomedica, Edwards Lifesciences Corp., ELITE LIFECARE, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, Heart Care India Co., Hemovent GmbH, Jarvik Heart Inc., Koninklijke Philips NV, LivaNova Plc, Medtronic Plc, Nipro Corp., Palex Medical SA, RAUMEDIC AG, Saati SpA, SONOTEC GmbH, SynCardia Systems LLC, and Terumo Group |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.